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Abstract
Background: Delirium is a well-known complication in cardiac surgery and intensive care unit (ICU) patients. However,
in many other settings its prevalence and clinical consequences are understudied. The aims of this study were: (1) To
assess delirium prevalence in a large, diverse cohort of acute care patients classified as either at risk or not at risk for
delirium; (2) To compare these two groups according to defined indicators; and (3) To compare delirious with non-
delirious patients regarding hospital mortality, ICU and hospital length of stay, nursing hours and cost per case.
Methods: This cohort study was performed in a Swiss university hospital following implementation of a delirium
management guideline. After excluding patients aged < 18 years or with a length of stay (LOS) < 1 day, 29′278 patients
hospitalized in the study hospital in 2014 were included.
Delirium period prevalence was calculated based on a Delirium Observation Scale (DOS) score≥ 3 and / or Intensive
Care Delirium Screening Checklist (ICDSC) scores ≥4.
Results: Of 10′906 patients admitted, DOS / ICDSC scores indicated delirium in 28.4%. Delirium was most prevalent
(36.2–40.5%) in cardiac surgery, neurosurgery, trauma, radiotherapy and neurology patients. It was also common in
geriatrics, internal medicine, visceral surgery, reconstructive plastic surgery and cranio-maxillo-facial surgery patients
(prevalence 21.6–28.6%). In the unadjusted and adjusted models, delirious patients had a significantly higher risk of
inpatient mortality, stayed significantly longer in the ICU and hospital, needed significantly more nursing hours and
generated significantly higher costs per case. For the seven most common ICD-10 diagnoses, each diagnostic group’s
delirious patients had worse outcomes compared to those with no delirium.
Conclusions: The results indicate a high number of patients at risk for delirium, with high delirium prevalence across
all patient groups. Delirious patients showed significantly worse clinical outcomes and generated higher costs.
Subgroup analyses highlighted striking variations in delirium period-prevalence across patient groups. Due to the high
prevalence of delirium in patients treated in care centers for radiotherapy, visceral surgery, reconstructive plastic surgery,
cranio-maxillofacial surgery and oral surgery, it is recommended to expand the current focus of delirium management
to these patient groups.
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Background
Delirium is a sudden acute mental change accompanying
acute illness. Characterized by disturbances of conscious-
ness, attention, cognition, psychomotor behavior and
emotions [1, 2], it affects 10 to 60% of all patients treated
in medical, surgical, medical-surgical mixed or general
wards [3–5], and up to 80% of those treated in intensive
care units (ICUs) [3, 6–10]. More than two dozen predis-
posing and precipitating delirium risk factors have been
identified, including male gender, older age (> 65 years),
prior delirium, co-morbidities (i.e., dementia, depression)
and severe illness [3, 11–13].
Delirium is linked to negative patient and institutional
outcomes including prolonged ICU and hospital length
of stay (LOS) [7, 14–17], higher mortality rates [14, 16,
18–20], cognitive decline or impaired cognitive functions
[20–23], restrictions in motor functionality [23, 24],
ongoing need for care in long-term care institutions [14, 15]
and a higher likelihood of discharge to destinations other
than home [23, 25].
From an economic perspective, delirium is strongly asso-
ciated with additional healthcare costs [17]. In the United
States (US), annual additional delirium-related healthcare
costs are estimated to range from 6.6 to 20.4 billion USD
(mean: 9014 USD per case) in ICU patients [26] and 38 to
152 billion USD per year in non-ICU patients aged 70 years
and older (range: 16,303 to 64,421 USD per case) [27].
The large number of patients affected by delirium dur-
ing hospitalization, the negative clinical outcomes, and the
severe economic consequences all call for action. In recent
years, several delirium management guidelines and / or
standardized programs were developed for the prevention,
early recognition, and / or treatment of delirium across all
hospital departments [28–32]. The results indicate that
multicomponent delirium management guidelines or pro-
grams are most efficient to reduce the delirium rates and
the delirium-linked negative outcomes, i.e., decreasing
LOS and institutionalization [31, 33, 34].
In 2012, in response to the delirium burden at the
study hospital –a Swiss university hospital–the
multi-professional Delir-Path (Detect Evaluate Control
Inpatient Risk factors, Prevent And Treat Hospital
Acquired Deliriums) project was started. It includes a
practice development part and a health service research
(HSR) part.
Delir-Path has five primary purposes: 1) to develop a
standardized multi-professional, multicomponent delirium
management guideline for the prevention, early recogni-
tion and treatment of delirium; 2) to implement the
delirium management guideline throughout the study
hospital and to monitor and evaluate the implementation
process based on defined outcomes; 3) to evaluate the
effectiveness, efficiency, and benefits of the implemented
multiprofessional delirium management protocol, both as
a whole and as single components, e.g., pharmacological
delirium treatment; 4) to develop and implement a system
for monitoring delirium incidence rates and the courses of
the underlying diseases (duration); 5) to develop and
establish a multicenter, multiprofessional Health Care
Service Research Program for effective, efficient and
cost-effective delirium management.
As a first step in a form of a pilot study an interprofes-
sional multicomponent delirium management guideline
was developed. The developed guideline contains interven-
tions for delirium prevention, risk stratification, screening
and diagnostics, non-pharmacological and pharmacological
treatment, as well as a multi-professional training program
(see Additional file 1). The guideline was implemented on
nine surgical and neurological wards and ICUs and its
benefits evaluated [35, 36]. Based on that pilot’s promising
results, the standardized delirium management guideline
was adapted and implemented hospital-wide in 2013 / 2014
[35, 36]. Concurrently, the HSR program was developed
further. In the study hospital, as of April 2018, this includes
a main study, more than 10 sub-studies [6, 36–43]. Further-
more, the program includes a multicenter study in ICU
settings. This study refers to the main study, which uses a
longitudinal cohort design.
To date, delirium management programs and / or de-
lirium bundles and related research have focused on the
best-known high delirium risk patient groups – predom-
inately ICU, cardiac and orthopaedic patients [3]. A
small number have also focused on medical and / are
palliative care groups [44, 45]. However, the literature
shows no delirium management programs implemented,
e.g., for haemato-oncological patients, although, based
on the typical courses of their conditions, fulfil the
criteria for a high delirium risk [46].
Because significant risk groups may remain undetected,
the Delir-Path main study included an entire university
hospital cohort of acute care patients. This allowed us to
study both delirium’s prevalence and the effect of the
implemented guideline across acute care patient groups.
Methods
Aims
The aims of this study were: (1) to assess delirium preva-
lence in a cohort of acute care patients classified as either
at risk or not at risk for delirium; (2) to compare these
two groups according to defined indicators, including
main diagnosis, care center, and admission and discharge
details; and (3) to compare delirious with non-delirious
patients regarding hospital mortality, ICU and hospital
LOS, nursing hours and cost per case.
Study design and setting
This study used data from the ongoing Delir-Path health
service research program [6, 36–43] conducted in a Swiss
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university hospital with 800 beds distributed across 43
departments and institutes. As a longitudinal cohort
study, it includes data of all eligible patients hospitalized
in the study hospital between January and December
2014, 1 year after the implementation of the delirium
guideline. Patients younger than 18 years of age, and those
hospitalized for less than 1 day, were excluded (Fig. 1).
Variables, measurements, data sources, data collection
Screening for and definition of delirium
In accordance with the implemented delirium manage-
ment guideline, all patients admitted to the regular
wards were screened for delirium once per shift with
the Delirium Observation Scale (DOS) [47] for at least
3 days, if they fulfilled the following criteria: a) ≥
65 years; or b) < 65 years with delirious symptoms, e.g.,
conspicuous symptoms such as disorientation or agita-
tion. If the DOS Score indicated no delirium develop-
ment for three consecutive days, the screening was
stopped. If the patients developed a delirium, the
screening was continued until the DOS score fell below
3 (see Additional file 1). All ICU patients with states of
consciousness allowing assessment (Richmond Agita-
tion Scale Score (RASS) [48] of − 3 to + 4) are screened
once per shift with the Intensive Care Delirium Screen-
ing Checklist (ICDSC) [49] (see Additional file 1).
The DOS is a 13-item screening tool for non-ICU
patients. It was developed to facilitate early recognition
of delirium according to the criteria of the Diagnostic
and Statistical Manual IV-TR. A DOS score ≥ 3 indicates
a delirium. The DOS’s sensitivity (82, 89%) and specifi-
city (86, 96%), as well as its reliability and validity were
confirmed in several studies [47, 50, 51].
The ICDSC is an 8-item screening tool developed to
detect delirium in ICU patients, with scores ≥4 indicating
delirium [49]. In several studies, the tool has shown good
sensitivity (64, 89, 99%), specificity (57, 64, 95%) and reli-
ability (kappa 0.67, 0.91, 0.92) [38, 49, 52].
For the current study, a patient was considered delirious
if he/she had at least once ICDSC score of ≥4 and / or a
DOS score ≥ 3.
Outcomes
To describe the entire sample and to compare patients with
and without delirium across patient subgroups, the follow-
ing five main outcomes were selected: (1) Mortality, i.e., the
frequency of patient deaths during hospitalization; (2) ICU
LOS; (3) hospital LOS; (4) nursing hours per case, i.e., the
Fig. 1 Sample and sampling per intervention group of patients hospitalized in 2014. Legend: DOS (Delirium Observation Scale); ICDSC (Intensive
Care Delirium Screening Checklist); LOS (Length of Stay)
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number of nursing hours spent per case for direct patient
care, assessed once per shift; and (5) total cost per case.
Other outcomes of interest and variables used as pa-
tient descriptors or as control variables were age, gender,
residency before admission to the hospital (e.g., home,
hospital), type of hospital admission (emergency, other),
care center (organizational unit: e.g. cardiac surgery, vis-
ceral surgery, internal medicine), principal diagnoses
(diagnostic codes drawn from the 19 ICD-10 chapters,
diagnoses other than delirium), comorbidities, the pres-
ence of one or more disorders (ICD- 10 codes) as de-
fined by Quan et al., [53], length of ICU stay, discharge
destination (the destination to which the patient was dis-
charged from the hospital, i.e., home, other institution),
and readmission rate.
All variables / data are documented regularly in the
patient medical records. They refer to the following data-
bases: the Swiss Federal Statistical Office (FSO) medical
and administrative database [54], the Minimal Data Set–
Intensive Care Unit (MDSi) [55], the patient performance
classification “Leistungserfassung in der Pflege” (LEP) [56]
database, and DOS and ICDSC delirium screening data.
The LEP performance classification is used for uniform
documentation of services in the healthcare sector, and
can be linked with other assessment, classification and
outcome data. Authorized hospital administrative staff ex-
tracted the required patient data and made them available
to the researchers. The researchers had no information
that could be used to identify the patients from whom
they had been collected. The data sets were linked based
on unique case identification numbers.
Statistical methods
Patient characteristics for the entire sample and subgroups
were described using means (with standard deviations),
medians (with 25 and 75% quartiles), or counts (and
percentages).
We calculated the period prevalence as the ratio of the
number of patients diagnosed with delirium over a given
period to the number of eligible individuals in the hospi-
talized population during that period, presented as a
percentage. We compared overall inpatient mortality of
delirious to non-delirious patients using generalized
linear models of the binomial family with logit link
function. We compared ICU and hospital length of stays
of delirious and non-delirious patients using Cox
proportional hazard models. Finally, we compared costs
per case and nursing hours using quantile regression. In
an additional step, we adjusted these differences in
mortality, LOS, cost and nursing hours by controlling
for age, gender, pre-admission residence type, type of
admission (emergency or not), Charlson co-morbidity
index [53], type of service, and ICU stay (yes/no). In
screened at-risk patients older than 65 years of age, we
also performed an ICD-10 diagnosis subgroup analysis
investigating differences between patients who devel-
oped delirium and those who did not. Five models
analogous to the overall patient data set were con-
structed (i.e., one for each outcome variable). Contrasts
were calculated 2. The two-sided level of significance
was set at P = 0.05. All statistical tasks were performed
using the R Statistical Package v. 3.4.2. In R, we used the
packages survival 2.41–3 for Cox proportional hazard
models and quantreg 5.35 for quantile regressions. Add-
itionally, we used lsmeans 2.27–61 to calculate subgroup
contrasts between delirious and non-delirious patients for
GLMs and Cox proportional hazard models. Subgroup
contrasts were calculated manually for quantile models,
and significance was calculated based on standard errors
following [57, 58].
Results
Participants and their characteristics
Of the 39′432 patients hospitalized in the study hospital
in 2014, 29′278 (74.2%) were identified as eligible for this
study and included in the analysis (Fig. 1). Characteristics
of the overall patient sample (patients with vs. without
delirium risk, delirious vs. non-delirious patients) are
described in Table 1.
Whereas patients not at risk were generally admitted as
elective (non-emergency) cases from home to the hospital,
the screened patients, particularly those in delirious states,
were more likely to have been transferred from another
hospital and / or admitted via emergency admission.
Post-admission, they were more likely to spend time in the
ICU and more likely to be discharged to a rehabilitation
center or another hospital (Table 1).
Delirium prevalence in different patient subgroups (type
of care, ICD-10 diagnosis)
In accordance with the implemented guideline, 10′906
(37.2%) of the total 29′278 patients were identified at risk
for delirium and screened. Of the screened group, 3′069
(28.1%) yielded at least one DOS score ≥ 3 and / or ICDSC
score ≥ 4, indicating a delirious state (Table 1). The num-
ber of delirious patients varied by type of care and ICD-10
diagnosis chapter. A delirious state was most frequent in
internal / general medicine patients, followed, in descend-
ing order of prevalence, by cardiac surgery, neurology,
neurosurgery and trauma surgery patients. This is partly
reflected in the ICD-10 chapter groups, where delirium
was more prevalent in patients with a principal diagnosis
related to the ICD-10 chapters IX (“Diseases of circulatory
system”), II (“Neoplasms”) and XIX (“Injury/poisoning of
external cause”) (Table 1).
The comparisons within and across the various care units
and ICD-10 chapter groups (Fig. 2) show that a delirious
state was most frequent in patients admitted to cardiac
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Table 1 Characteristics of the patients: entire sample, patient at risk screened for a delirium, patient at risk with and without a
delirious state
Entire sample Screened sample – patient at risk for a
delirium
Endpoints / Variables Total Not screened
(not at risk for a delirium)
Screened
(at risk for a delirium)
Non-delirious
DOS < 3, ICDSC < 4
Delirious
DOS ≥ 3, ICDSC≥ 4
Total n (%) 29′278 18′372 (62.8) 10′906 (37.2) 7′837 (71.9) 3′069 (28.1)
Age [years] mean (SD) 54.7 (19.2) 47.0 (16.9) 67.6 (15.4) 67.3 (15.2) 68.4 (15.8)
Gender [male] n (%) 14′147 (48.3) 7′672 (41.8) 6′475 (59.4) 4′601 (58.7) 1′874 (61.1)
Residency prior admission n (%)
Home 25′842 (88.3) 17′003 (92.5) 8′839 (81.0) 6′730 (85.9) 2′109 (68.7)
Other hospital 2′386 (8.1) 928 (5.1) 1'458 (13.4) 813 (10.4) 645 (21.0)
Nursing home 402 (1.4) 121 (0.7) 281 (2.6) 125 (1.6) 156 (5.1)
Other residency 462 (1.6) 245 (1.3) 217 (2.0) 99 (1.3) 118 (3.8)
With home care 186 (0.6) 75 (0.4) 111 (1.0) 70 (0.9) 41 (1.3)
Emergency admission n (%) 13′862 (47.3) 8′727 (47.5) 5′135 (47.1) 3′280 (41.9) 1′855 (60.4)
Type of care n (%)
Internal / general medicine 7′198 (24.6) 4′218 (23.0) 2′980 (27.3) 2′141 (27.3) 839 (27.3)
Cardiac surgery 1′392 (4.8) 249 (1.4) 1′143 (10.5) 680 (8.7) 463 (15.1)
Neurology 1′516 (5.2) 517 (2.8) 999 (9.2) 637 (8.1) 362 (11.8)
Neurosurgery 968 (3.3) 173 (0.9) 795 (7.3) 480 (6.1) 315 (10.3)
Trauma surgery 2′090 (7.1) 1'360 (7.4) 730 (6.7) 462 (5.9) 268 (8.7)
Other service 16′114 (55.0) 11′855 (64.5) 4′259 (39.1) 3′437 (43.9) 822 (26.8)
ICD-10 chapter n (%)
IX. Diseases of circulatory system 4′538 (15.5) 1′218 (6.6) 3′320 (30.4) 2′247 (28.7) 1′073 (35.0)
II. Neoplasms 5′665 (19.3) 3′182 (17.3) 2′483 (22.8) 1′915 (24.4) 568 (18.5)
XIX. Injury/poisoning of external cause 2′997 (10.2) 1′938 (10.5) 1′059 (9.7) 653 (8.3) 406 (13.2)
XI. Diseases of the digestive system 1′954 (6.7) 1'326 (7.2) 628 (5.8) 448 (5.7) 180 (5.9)
VI. Diseases of nervous system 933 (3.2) 399 (2.2) 534 (4.9) 359 (4.6) 175 (5.7)
I. Infections/parasites 728 (2.5) 492 (2.7) 236 (2.2) 120 (1.5) 116 (3.8)
X. Diseases of respiratory system 1'440 (4.9) 966 (5.3) 474 (4.3) 367 (4.7) 107 (3.5)
Other ICD-10 chapters 11,'023 (37.6) 8'851 (48.2) 2'172 (19.9) 1'728 (22.0) 444 (14.5)
ICU stay n (%) 4'002 (13.7 502 (2.7) 3'500 (32.1) 1'912 (24.4) 1'588 (51.7)
Discharged n (%)
Home 23,'679 (80.9) 16′767 (91.3) 6′912 (63.4) 5′869 (74.9) 1′043 (34.0)
Rehab 2'584 (8.8) 521 (2.8) 2'063 (18.9) 1′106 (14.1) 957 (31.2)
Other hospital 929 (3.2) 219 (1.2) 710 (6.5) 343 (4.4) 367 (12.0)
Nursing home 599 (2.0) 190 (1.0) 409 (3.8) 172 (2.2) 237 (7.7)
Others service 266 (0.9) 120 (0.7) 146 (1.3) 57 (0.7) 89 (2.9)
Missing 503 (1.7) 279 (1.5) 224 (2.1) 131 (1.7) 93 (3.0)
Re-admissions n (%) 910 (3.1) 546 (3.0) 364 (3.3) 252 (3.2) 112 (3.6)
Outcomes
Hospital mortality n (%) 718 (2.5) 276 (1.5) 442 (4.1) 159 (2.0) 283 (9.2)
LOS in the hospital d median
[Q1, Q3]
5.00 [3, 10] 4 [3, 7] 8 [4, 15 7 [4, 12] 13 [7, 23],
Nursing hours per case h median
[Q1, Q3]
30.1 [17.7, 59.5] 24.1 [15.7, 39.9] 52.5 [26.0, 107.7] 41.0 [22.2, 76.0] 114.5 [56.7, 240.5]
Cost per case CHF 11′128
[6′667, 22′861]
8′764
[5′788, 14′515]
20′875,
[10′463, 42′271]
16′662
[9067, 32′413]
40′259
[19′235, 80′245]
Legend: DOS delirium observation scale; ICDSC intensive care delirium screening checklist; ICU intensive care unit
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surgery units (40.5%), followed by radiotherapy (39.7%),
neurosurgery (39.6%), trauma surgery (36.7%) and neur-
ology (36.2%) care (Fig. 2). With reference to the ICD-10
chapters, delirium was most frequent in patients with a
principal diagnosis related to group V (“Mental / behavioral
disorders”) (62.9%), followed by groups I (“Infections/para-
site diseases”) (49.2%), XIX (“Injury/poisoning/external
causes”) (38.3%), VI (“Diseases of the nervous system”)
(32.8%), IX (“Diseases of the circulatory system”) (32.3%),
XI (“Diseases of the digestive system”) (28.7%), III (“Blood
diseases”) (27.9%) and IV (Endocrine/nutritional/metabolic
diseases) (27.9%) (Fig. 2).
Mortality, ICU and hospital length of stay, mortality, cost
and nursing hours per case in delirious and non-delirious
patients
The comparison of the raw number of patients identified,
in accordance with the implemented guideline, as not at
risk for a delirium (n = 18′372) with those identified as at
risk (n = 10′906) and screened shows that at-risk patients
stayed twice as long in hospital, accounting for twice the
number of nursing hours and twice the total cost per case.
The comparison of the screened patients identified as not
delirious (n = 7′837) versus delirious (n = 3′069) shows
the same pattern (Table 1).
Fig. 2 Percentage of patients diagnosed with delirium (DOS, ICDSC scores) within type of care and ICD-10 chapter of main diagnosis. Legend/
notes: Patients with missing values were ignored when calculating percentages
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In screened patients 65 years or older, cases with a de-
lirium were at a higher risk of dying (crude mortality OR
(95% CI): 5.46 (4.85 to 6.15), p < 0.001), stayed longer at
the ICU (crude HR (95% CI) for discharge: 0.40 (0.38 to
0.42), p < 0.001) and in the hospital (crude HR (95% CI)
for discharge: 0.25 (0.24 to 0.26), p < 0.001), they caused
more nursing hours (crude median difference nursing
hours (95% CI): 64.8 (62.0 to 67.6), p < 0.001, and they
cost more (crude median cost difference [in thousand
CHF] (95% CI): 20.9 (19.9 to 21.9), < 0.001). If we ad-
justed for age, gender, pre-admission residence type, type
of admission (emergency or not), Charlson co-morbidity
index, type of service, and ICU stay, these differences
were less pronounced, but still highly significant (ad-
justed mortality OR (95% CI): 3.18 (2.79 to 3.63), p
< 0.001; adjusted HR (95% CI) for ICU discharge: 0.39
(0.36 to 0.41), p < 0.001; adjusted HR (95% CI) for hos-
pital discharge: 0.43 (0.41 to 0.45), p < 0.001; adjusted
median difference nursing hours (95% CI): 37.3 (35.0 to
39.5), p < 0.001; adjusted median cost difference [in
thousand CHF] (95% CI): 10.0 (9.3 to 10.6), < 0.001).
In our further exploration of the differences between
non-delirious and delirious patients, only patients
≥65 years who were judged at risk and screened for a
delirium (n = 7′446) were included. Of these, 2′057
(38%) were identified as delirious. (Table 2). For a
comparison between the non-delirious and the delirious
patients, a set of non-adjusted outcome models were fit
across seven ICD-10 diagnoses groups with reference to
the five selected outcomes (Table 2). Compared to
non-delirious patients, those who were delirious were
significantly more likely to die (3–11 times). They were
also significantly less likely to be discharged from the
ICU (1–9 times) or hospital (3–9 times). This applied to
all patients except those with infectious diseases and
diseases of the respiratory system: in their cases, the
differences were not significant. Delirious patients also
required significantly more nursing hours (1.5–4 times)
and generated significantly higher costs per case (1.5 to
3.5 times) (Table 2). Differences in overall hospital LOS
for screened patients with versus without delirium are
displayed in Fig. 3.
Discussion
Of all eligible adult patients hospitalized in 2014, almost a
third was identified as at risk for delirium and screened
accordingly. Of those screened, nearly one-third yielded a
DOS and / or ICDSC score indicating a delirium. In
accordance with available evidence, delirium was more
frequent in males and patients hospitalized for cardiac
surgery [3, 6, 59, 60], neurosurgery, traumatology, radio-
therapy, and neurological care, with period-prevalences
from 36.2 to 40.5%. Elsewhere, with period-prevalence’s
ranging from 21.6 to 28.6%, delirium also occurred
frequently in patients treated in geriatric and internal / gen-
eral medicine, as well as in visceral surgery. Similar preva-
lences were found in patients recovering from visceral
surgery, reconstructive plastic surgery, cranio-maxillo-facial
surgery, and oral surgery. This new finding underscores the
importance of a standard delirium management guideline
for use across patient groups.
The comparison of the delirium point-prevalence rate
by ICD-10 diagnosis chapter and the presence of delirium
in patients within and between groups partly reflected
these rates. Delirious states were most frequent in patients
with main diagnoses referring to the ICD-10 chapters on
mental / behavioral disorders, infections, injuries, poison-
ing, or diseases of the nervous, circulatory, digestive, blood
and endocrine /nutritional /metabolic systems. The high
prevalence of delirious states in patients with diagnoses
related to Chapter V (mental / ‘behavioral disorders) can
be explained by that chapter’s direct focus on psychiatric
disorders. The other diagnosis chapters refer to diseases
such as infections or abnormal laboratory values, e.g.,
abnormal creatinine, serum sodium, glucose or potassium
levels and metabolic acidosis, which are known precipitat-
ing factors of delirium [11, 61, 62].
Our subgroup analysis by ICD-10 diagnosis chapter
indicated not only that delirious patients were significantly
more likely to die, but that they required roughly twice
most non-delirious groups’ nursing hours, ICU days,
hospital stay, and overall financial expenditure per case.
The one exception was the category of non-delirious
patients with infections and respiratory diseases, whose
ICU stays were not significantly lower (Table 2). These
demonstrated negative outcomes in patients with delirium
correspond with recent findings of significant differences
between delirious and non-delirious patients’ mortality
rates [14, 19, 63–65], ICU LOS [14, 16, 19, 66, 67],
hospital LOS [14, 16, 17, 19, 66, 67], nursing hours per
case [68] and total cost [17, 26, 67]. The demonstrated
variation in these outcomes regarding the seven top
ICD-10 diagnosis groups adds to the current evidence.
Such marked differences between main outcomes suggest
that group-specific characteristics and risk factors influ-
ence delirium-related outcomes and consequences. Still, it
remains unclear whether delirium contributes to poorer
outcomes, impacts the underlying illness’s trajectory [69],
or simply indicates greater disease severity.
As our results show, compared to non-delirious
patients, those with delirium were more often admitted
from other hospitals and less frequently discharged
home. In addition, they were treated in the ICU more
frequently (table1). This suggests that, compared to their
non-delirious counterparts, the delirious were more
seriously ill or had more exacerbated functional health
status impairment. Since serious disease and functional
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Table 2 In-hospital mortality, LOS in the ICU and in hospital, nursing hours and costs per case in delirious and non-delirious patients
with a main diagnosis, which refers to the top-seven ICD-10 diagnoses chapters
Outcome by ICD-10 chapter Non-delirious
(DOS < 3, ICDSC < 4)
Delirious
(DOS ≥ 3, ICDSC ≥4)
Difference p
Mortality n n dead (%) n n dead (%) odds ratio (95% CI)
Diseases of circulatory system 1'470 41 (3%) 758 67 (9%) 3.38 (2.27 to 5.04) < 0.001
Neoplasms 1'295 36 (3%) 380 51 (13%) 5.42 (3.48 to 8.45) < 0.001
Injury/poisoning of external cause 446 12 (3%) 256 28 (11%) 4.44 (2.22 to 8.90) < 0.001
Diseases of the digestive system 315 5 (2%) 101 15 (15%) 10.81 (3.82 to 30.59) < 0.001
Diseases of nervous system 242 3 (1%) 113 7 (6%) 5.26 (1.33 to 20.74) 0.0177
Infections/parasites 80 5 (6%) 78 22 (28%) 5.89 (2.10 to 16.52) < 0.001
Diseases of respiratory system 232 7 (3%) 59 12 (20%) 8.21 (3.07 to 21.95) < 0.001
other 1'214 6 (0%) 253 14 (6%) 11.79 (4.49 to 30.98) < 0.001
ICU LOS [days] n median (95% CI) n median (95% CI) hazard ratio (95% CI)
Diseases of circulatory system 331 1.0 (0.9 to 1.0) 384 3.1 (2.7 to 4.0) 0.43 (0.37 to 0.50) < 0.001
Neoplasms 174 0.9 (0.9 to 0.9) 147 2.9 (1.9 to 4.5) 0.37 (0.29 to 0.46) < 0.001
Injury/poisoning of external cause 61 0.9 (0.8 to 1.4) 133 3.7 (3.0 to 5.4) 0.47 (0.34 to 0.64) < 0.001
Diseases of the digestive system 40 1.0 (0.9 to 1.7) 47 10.8 (4.6 to 13.5) 0.28 (0.18 to 0.44) < 0.001
Diseases of nervous system 41 0.8 (0.7 to 0.8) 38 1.8 (0.8 to 7.5) 0.26 (0.16 to 0.40) < 0.001
Infections/parasites 8 2.0 (0.9 to –) 29 13.5 (5.2 to 25.1) 0.65 (0.22 to 1.90) 0.434
Diseases of respiratory system 33 1.1 (1.0 to 2.0) 17 1.8 (1.0 to 15.0) 0.64 (0.34 to 1.17) 0.148
other 74 0.9 (0.9 to 1.5) 56 4.9 (3.9 to 11.0) 0.34 (0.24 to 0.49) < 0.001
Hospital LOS [days] n median (95% CI) n median (95% CI) hazard ratio (95% CI)
Diseases of circulatory system 1'470 8 (8 to 9) 758 71 (43 to –) 0.21 (0.18 to 0.25) < 0.001
Neoplasms 1'295 7 (6 to 7) 380 26 (22 to 37) 0.30 (0.25 to 0.35) < 0.001
Injury/poisoning of external cause 446 8 (7 to 9) 256 37 (33 to –) 0.23 (0.17 to 0.30) < 0.001
Diseases of the digestive system 315 6 (6 to 7) 101 31 (21 to –) 0.26 (0.19 to 0.36) < 0.001
Diseases of nervous system 242 7 (6 to 7) 113 25 (15 to –) 0.31 (0.23 to 0.43) < 0.001
Infections/parasites 80 7 (6 to 12) 78 58 (43 to –) 0.18 (0.11 to 0.30) < 0.001
Diseases of respiratory system 232 8 (7 to 10) 59 17 (14 to –) 0.42 (0.27 to 0.65) < 0.001
other 1'309 5 (5 to 6) 312 19 (15 to 24) 0.32 (0.27 to 0.38) < 0.001
Nursing hours [in hours] n median (25%; 75% quantiles) n median (25%; 75% quantiles) median difference (95% CI)
Diseases of circulatory system 1'470 39.9 (20.3; 73.4) 758 119.2 (63.5; 226.4) 79.2 (70.1 to 88.4) < 0.001
Neoplasms 1'295 36.9 (21.3; 67.7) 380 101.2 (42.1; 192.6) 63.9 (48.3 to 79.5) < 0.001
Injury/poisoning of external cause 446 44.1 (24.8; 74.5) 256 102.9 (51.5; 195.8) 58.8 (42.2 to 75.5) < 0.001
Diseases of the digestive system 315 28.9 (19.6; 57.8) 101 100.2 (37.2; 326.3) 71.3 (25.1 to 117.5) 0.00255
Diseases of nervous system 242 27.9 (18.5; 45.5) 113 71.7 (37.6; 122.7) 43.9 (28.4 to 59.5) < 0.001
Infections/parasites 80 31.8 (17.2; 67.2) 78 128.2 (62.9; 298.3) 95.8 (74.1 to 117.6) < 0.001
Diseases of respiratory system 232 38.8 (19.4; 73.6) 59 66.5 (41.6; 120.3) 27.8 (18.2 to 37.3) < 0.001
other 1'309 25.1 (15.9; 46.1) 312 62.6 (29.0; 142.0) 37.6 (27.6 to 47.6) < 0.001
Cost [in thousand CHF] n median (25%; 75% quantiles) n median (25%; 75% quantiles) median difference (95% CI)
Diseases of circulatory system 1'470 20.4 (11.6; 40.6) 758 48.3 (23.3; 79.7) 27.7 (23.0 to 32.4) < 0.001
Neoplasms 1'295 13.7 (7.2; 27.4) 380 35.3 (15.4; 63.7) 21.5 (17.8 to 25.3) < 0.001
Injury/poisoning of external cause 446 15.2 (9.0; 25.2) 256 34.9 (19.6; 67.7) 19.5 (15.6 to 23.4) < 0.001
Diseases of the digestive system 315 11.3 (6.8; 19.8) 101 31.0 (13.0; 90.0) 19.7 (9.7 to 29.7) < 0.001
Diseases of nervous system 242 10.9 (7.8; 18.3) 113 20.6 (13.5; 44.0) 9.8 (6.6 to 13.0) < 0.001
Infections/parasites 80 9.9 (6.1; 19.0) 78 35.4 (16.6; 97.4) 24.4 (18.1 to 30.7) < 0.001
Diseases of respiratory system 232 12.4 (7.6; 24.8) 59 18.8 (13.1; 29.8) 6.5 (4.2 to 8.7) < 0.001
other 1'214 9.2 (6.0; 15.9) 253 16.6 (9.0; 32.6) 7.4 (4.7 to 10.1) < 0.001
Legend: ICU intensive care unit; LOS length of stay, missing values for LOS due to censoring are indicated with a dash (−),
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impairment are known predictors of delirium [3, 11, 12],
despite controlling for all known confounders in the first
set of models, which we run for the comparison of the
non-delirious and delirious patients, we cannot exclude
the possibility that these factors contributed to the out-
come differences discussed above.
This study has a number of notable strengths and
limitations. One strength is that its analyses covered all
eligible patients treated in the study hospital over one full
calendar year. The sample included a broad range of sur-
gical, medical, and mixed surgical-medical patient groups
– several of which, to our knowledge, were studied for the
first time in this context. Two analyses were particularly
important: that of the patient subgroup identified as at
risk for delirium; and, within this group, the separate ana-
lysis of only the older at-risk patients by ICD-10 main
diagnosis chapter. Both provided important insights
regarding the occurrence of delirium in diverse subgroups.
Limitations include an observational design and the inclu-
sion of only a single center, both of which limit the
generalizability of the results and allow no inferences
regarding causal relations. Another limitation is that our
chosen approach to identifying delirious patients – clas-
sing a patient as delirious if he/she had at least once an
DOS score ≥ 3 and / or a ICDSC score of ≥4 - might have
been too sensitive, i.e., it might have led to delirium rate
overestimation. Further, the use of existing clinical data
restricted both the number of variables and the overall
adequacy of the dataset regarding our needs. This and the
large sample size, for example, made a precise calculation
of delirium intensity and duration unfeasible. Finally, in
the study hospital, roughly 2′000 clinicians participated in
delirium screening. Although these clinicians’ delirium
training covered interrater reliability, a smaller research
team may have yielded more reliable assessment results.
I.e., while the use of validated screening tools ensured that
detection of patients with delirium was reliable within ac-
ceptable tolerances. Further studies, ideally of a prospect-
ive nature, will be necessary to confirm our findings.
Conclusions
The results reported here indicate not only high numbers
of patients identified as at risk for a delirium but also high
delirium prevalence across most patient groups. This
underscores the relevance of this topic and the need for
systematic delirium management to prevent, recognize,
and treat delirium across patient groups.
In both the unadjusted and adjusted models, compared
to the patients without delirium, delirious patients’ ≥
65 year had a significantly higher mortality rate and longer
ICU and hospital LOS. They also required more nursing
hours and generated much higher cost per case. In the
subgroup analysis conducted by ICD-10 diagnosis chapter,
for the unadjusted models, each diagnostic group’s deliri-
ous patients had worse outcomes compared to those with
no delirium. However, considering that, as discussed
Fig. 3 Duration of the hospital length of stay in delirious and non-delirious patients
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above, the current study cannot indicate causality, is it
essential to test these findings with a study design that
allows causal inferences.
Our subgroup analyses highlighted striking variations in
delirium period-prevalence across patient groups. Several
of these differences, e.g., the frequent occurrence of delir-
ium in cardiac surgery or geriatric patients, support previ-
ous findings. One new finding – which requires further
attention – is the high prevalence of delirium in radiother-
apy, visceral surgery, reconstructive plastic surgery, and
cranio-maxillo-facial or oral surgery patients – all groups
who have thus far fallen either outside or only marginally
within the scope of clinical delirium management.
In the subgroup analysis according to the ICD-10 diag-
nosis chapters, patient diagnoses referring to known
delirium precipitating factors, e.g., infection/parasites,
injury, poisoning, or endocrine /nutritional /metabolic
diseases, were linked with elevated delirium prevalence.
Therefore, in addition to patients currently in the focus
of standard delirium management (i.e., ICU, cardiac and
orthopaedic patients), it is recommended to expand that
focus to include those treated in care centers for radio-
therapy, visceral surgery, reconstructive plastic surgery,
cranio-maxillo-facial and oral surgery.
Finally, the used approach described above to identify
patients at risk for a delirium, timely screening, detection
and identification of delirious patients can easily be added
to standard clinical practice. From a scientific perspective,
this approach allows quick classification of patients into
three groups with significant and clinically relevant out-
comes: (1) those not at risk, for whom delirium screening
is unnecessary; (2) those at risk and screened, who do not
develop a delirious state; and (3) those at risk and
screened and who develop a delirious state.
Additional file
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